Literature DB >> 8601268

The tablet splitter: barrier to compliance or cost-saving instrument?

S M Carr-Lopez1, M S Mallett, T Morse.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 8601268     DOI: 10.1093/ajhp/52.23.2707

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  6 in total

1.  Time series evaluation of an intervention to increase statin tablet splitting by general practitioners.

Authors:  Jennifer M Polinski; Sebastian Schneeweiss; Malcolm Maclure; Blair Marshall; Samuel Ramsden; Colin Dormuth
Journal:  Clin Ther       Date:  2011-02       Impact factor: 3.393

2.  Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

3.  Potential savings from splitting newer antidepressant medications.

Authors:  Carl I Cohen; Sara I Cohen
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  The practice of splitting tablets: cost and therapeutic aspects.

Authors:  John Bachynsky; Cheryl Wiens; Krystal Melnychuk
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.

Authors:  Rakhi B Shah; Jarrod S Collier; Vilayat A Sayeed; Arthur Bryant; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-08-26       Impact factor: 3.246

6.  Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.

Authors:  Khairi M S Fahelelbom; Moawia M M Al-Tabakha; Nermin A M Eissa; Jeevani Javadi
Journal:  Sci Pharm       Date:  2016-10-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.